Worth reading
65In focus
Scored from 5 of 6 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
997429
SharesWording
Definitive
How definitive the wording is.Decision and Details
Transfer of shares allotted through a third-party allotment
Implementation31 July 2026 (completed)
AmountTransfer price: ¥2,300 per share
Quantity / scaleNumber of shares allotted: 997,429 shares; number of shares transferred: 997,429 shares
Reason
Sale based on its investment policy
| Item | Details |
|---|---|
| Matter Covered | Transfer of shares allotted through a third-party allotment |
| Implementation Date | 31 July 2026 (completed) |
| Amount | Transfer price: ¥2,300 per share |
| Quantity / scale | Number of shares allotted: 997,429 shares; number of shares transferred: 997,429 shares |
| Reason | Sale based on its investment policy |
Items this document does not state (7)
Decision-Making BodyDecision DatePeriod CoveredImpact on Business PerformanceGoverning RuleRelated previous disclosuresFuture plans
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Sale based on the investment policy of Hisamitsu Pharmaceutical Co., Ltd., the allottee.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.